Digital pathology and artificial intelligence in translational medicine and clinical practice
出版年份 2021 全文链接
标题
Digital pathology and artificial intelligence in translational medicine and clinical practice
作者
关键词
-
出版物
MODERN PATHOLOGY
Volume 35, Issue 1, Pages 23-32
出版商
Springer Science and Business Media LLC
发表日期
2021-10-06
DOI
10.1038/s41379-021-00919-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pathologist Concordance for Ovarian Carcinoma Subtype Classification and Identification of Relevant Histologic Features Using Microscope and Whole Slide Imaging: A Multisite Observer Study
- (2021) Marios A. Gavrielides et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- The human‐in‐the‐loop: An evaluation of pathologists’ interaction with AI in clinical practice
- (2021) Anna C.S Bodén et al. HISTOPATHOLOGY
- Hidden Variables in Deep Learning Digital Pathology and Their Potential to Cause Batch Effects: Prediction Model Study
- (2021) Max Schmitt et al. JOURNAL OF MEDICAL INTERNET RESEARCH
- Deep learning in histopathology: the path to the clinic
- (2021) Jeroen van der Laak et al. NATURE MEDICINE
- Response to our reviewers
- (2021) Juan Manuel Durán et al. JOURNAL OF MEDICAL ETHICS
- Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence
- (2021) Gary S Collins et al. BMJ Open
- Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) Study
- (2021) Janis M Taube et al. Journal for ImmunoTherapy of Cancer
- Hierarchical graph representations in digital pathology
- (2021) Pushpak Pati et al. MEDICAL IMAGE ANALYSIS
- The Society for Immunotherapy in Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation
- (2020) Janis M Taube et al. Journal for ImmunoTherapy of Cancer
- Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective
- (2020) Lisa Browning et al. JOURNAL OF CLINICAL PATHOLOGY
- Classification and mutation prediction based on histopathology H&E images in liver cancer using deep learning
- (2020) Mingyu Chen et al. npj Precision Oncology
- Digital pathology and computational image analysis in nephropathology
- (2020) Laura Barisoni et al. Nature Reviews Nephrology
- Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer
- (2020) Zhe Gong et al. Cancer Medicine
- Clinical Trials for Artificial Intelligence in Cancer Diagnosis: A Cross-Sectional Study of Registered Trials in ClinicalTrials.gov
- (2020) Jingsi Dong et al. Frontiers in Oncology
- Deep neural network models for computational histopathology: A survey
- (2020) Chetan L. Srinidhi et al. MEDICAL IMAGE ANALYSIS
- Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American Pathologists
- (2019) Marilyn M Bui et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Quantitative Characterization of CD8+ T Cell Clustering and Spatial Heterogeneity in Solid Tumors
- (2019) Chang Gong et al. Frontiers in Oncology
- Whole slide imaging equivalency and efficiency study: experience at a large academic center
- (2019) Matthew G. Hanna et al. MODERN PATHOLOGY
- CD8+ T cells in tumor parenchyma and stroma by image analysis (IA) and gene expression profiling (GEP): Potential biomarkers for immuno-oncology (I-O) therapy.
- (2019) Peter M Szabo et al. JOURNAL OF CLINICAL ONCOLOGY
- Applications of machine learning in drug discovery and development
- (2019) Jessica Vamathevan et al. NATURE REVIEWS DRUG DISCOVERY
- Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy
- (2019) Sonja Althammer et al. Journal for ImmunoTherapy of Cancer
- Complete Digital Pathology for Routine Histopathology Diagnosis in a Multicenter Hospital Network
- (2019) Juan Antonio Retamero et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Pre-Analytic Variables and Tissue Stewardship for Reliable Next-Generation Sequencing (NGS) Clinical Analysis
- (2019) Paolo A. Ascierto et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Computational Pathology Definitions, Best Practices, and Recommendations for Regulatory Guidance: A White Paper from the Digital Pathology Association
- (2019) Esther Abels et al. JOURNAL OF PATHOLOGY
- Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
- (2019) Jakob Nikolas Kather et al. NATURE MEDICINE
- Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade
- (2019) Steve Lu et al. JAMA Oncology
- Deep learning outperformed 11 pathologists in the classification of histopathological melanoma images
- (2019) Achim Hekler et al. EUROPEAN JOURNAL OF CANCER
- Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology
- (2019) Kaustav Bera et al. Nature Reviews Clinical Oncology
- PD-L1 expression in gastric cancer determined by digital image analyses: pitfalls and correlation with pathologist interpretation
- (2019) Han-Na Kim et al. VIRCHOWS ARCHIV
- LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer
- (2019) Cinzia Solinas et al. Cancers
- 2021PQuantitative spatial profiling of lymphocyte-activation gene 3 (LAG-3)/major histocompatibility complex class II (MHC II) interaction in gastric and urothelial tumors
- (2019) C V Hedvat et al. ANNALS OF ONCOLOGY
- Stable FIX Expression and Durable Reductions in Bleeding and Factor IX Consumption for up to 4 Years Following AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B
- (2019) Wolfgang Miesbach et al. BLOOD
- Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
- (2019) Julie E Stein et al. CLINICAL CANCER RESEARCH
- Deep learning based on standard H&E images of primary melanoma tumors identifies patients at risk for visceral recurrence and death
- (2019) Prathamesh M. Kulkarni et al. CLINICAL CANCER RESEARCH
- Deep learning-based classification of mesothelioma improves prediction of patient outcome
- (2019) Pierre Courtiol et al. NATURE MEDICINE
- Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
- (2018) T R Cottrell et al. ANNALS OF ONCOLOGY
- PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
- (2018) Ming Sound Tsao et al. Journal of Thoracic Oncology
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Noninvasive detection of macrophage activation with single-cell resolution through machine learning
- (2018) Nicolas Pavillon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Not Just Digital Pathology, Intelligent Digital Pathology
- (2018) Balazs Acs et al. JAMA Oncology
- Measuring multiple parameters of CD8+ tumor-infiltrating lymphocytes in human cancers by image analysis
- (2018) Keith E. Steele et al. Journal for ImmunoTherapy of Cancer
- Computer-extracted features relating to spatial arrangement of tumor infiltrating lymphocytes to predict response to nivolumab in non-small cell lung cancer (NSCLC).
- (2018) Cristian Barrera et al. JOURNAL OF CLINICAL ONCOLOGY
- Computer extracted features of cancer nuclei from H&E stained tissues of tumor predicts response to nivolumab in non-small cell lung cancer.
- (2018) Xiangxue Wang et al. JOURNAL OF CLINICAL ONCOLOGY
- CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
- (2018) Yelena Y. Janjigian et al. JOURNAL OF CLINICAL ONCOLOGY
- A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
- (2018) Roger Sun et al. LANCET ONCOLOGY
- Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning
- (2018) Nicolas Coudray et al. NATURE MEDICINE
- Prognostic Factors for Checkpoint Inhibitor Based Immunotherapy: An Update With New Evidences
- (2018) Xinyu Yan et al. Frontiers in Pharmacology
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precision immunoprofiling by image analysis and artificial intelligence
- (2018) Viktor H. Koelzer et al. VIRCHOWS ARCHIV
- A Practical Guide to Whole Slide Imaging: A White Paper From the Digital Pathology Association
- (2018) Mark D. Zarella et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
- (2017) Babak Ehteshami Bejnordi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer
- (2017) Reinhard Büttner et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
- (2017) Leora Horn et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Avelumab for patients with previously treated metastatic or recurrent non-small-cell lung cancer (JAVELIN Solid Tumor): dose-expansion cohort of a multicentre, open-label, phase 1b trial
- (2017) James L Gulley et al. LANCET ONCOLOGY
- PD-L1 immunohistochemistry in clinical diagnostics of lung cancer: inter-pathologist variability is higher than assay variability
- (2017) Hans Brunnström et al. MODERN PATHOLOGY
- Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer
- (2017) Laurence Buisseret et al. MODERN PATHOLOGY
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
- (2017) David P. Carbone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
- (2017) Julienne L. Carstens et al. Nature Communications
- Benchmarking of Whole Exome Sequencing and Ad Hoc Designed Panels for Genetic Testing of Hereditary Cancer
- (2017) Lídia Feliubadaló et al. Scientific Reports
- Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
- (2017) Paul C. Tumeh et al. Cancer Immunology Research
- A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer
- (2017) David L. Rimm et al. JAMA Oncology
- Classification of breast cancer histology images using Convolutional Neural Networks
- (2017) Teresa Araújo et al. PLoS One
- Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer
- (2017) Michel E. Vandenberghe et al. Scientific Reports
- Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent
- (2017) Angel Cruz-Roa et al. Scientific Reports
- Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
- (2017) Sami Blom et al. Scientific Reports
- Diagnostic Immunohistochemistry: What Can Go Wrong and How to Prevent It
- (2016) Allen M. Gown ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated with neoadjuvant–adjuvant trastuzumab after 2 years of treatment-free follow-up
- (2016) Christian Jackisch et al. EUROPEAN JOURNAL OF CANCER
- Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms
- (2016) Thomas P Ahern et al. JOURNAL OF CLINICAL PATHOLOGY
- Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
- (2016) Louis Fehrenbacher et al. LANCET
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
- (2016) Corey J Langer et al. LANCET ONCOLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- International Clinical Guidelines for the Adoption of Digital Pathology: A Review of Technical Aspects
- (2016) Marcial García-Rojo PATHOBIOLOGY
- Comprehensive Immunohistochemistry: Digital, Analytical and Integrated
- (2016) Arvydas Laurinavicius et al. PATHOBIOLOGY
- Novel technologies and emerging biomarkers for personalized cancer immunotherapy
- (2016) Jianda Yuan et al. Journal for ImmunoTherapy of Cancer
- Recent developments in multiplexing techniques for immunohistochemistry
- (2015) Angela R Dixon et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology
- (2015) Andreas Heindl et al. LABORATORY INVESTIGATION
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma
- (2015) Zipei Feng et al. Journal for ImmunoTherapy of Cancer
- Dynamics of Allograft Fibrosis in Pediatric Liver Transplantation
- (2014) C. Venturi et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis
- (2014) Edward C. Stack et al. METHODS
- Digital pathology and image analysis in tissue biomarker research
- (2014) Peter W. Hamilton et al. METHODS
- Central Pathology Review for Phase III Clinical Trials: The Enabling Effect of Virtual Microscopy
- (2013) Pawel Mroz et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Validating Whole Slide Imaging for Diagnostic Purposes in Pathology: Guideline from the College of American Pathologists Pathology and Laboratory Quality Center
- (2013) Liron Pantanowitz et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Pathology is a necessary and informative tool in oncology clinical trials
- (2013) Iris D Nagtegaal et al. JOURNAL OF PATHOLOGY
- Pathology in drug discovery and development
- (2013) Adrian M Jubb et al. JOURNAL OF PATHOLOGY
- Identification and use of biomarkers in treatment strategies for triple-negative breast cancer subtypes
- (2013) Brian D Lehmann et al. JOURNAL OF PATHOLOGY
- Automated image analysis method for detecting and quantifying macrovesicular steatosis in hematoxylin and eosin-stained histology images of human livers
- (2013) Nir I. Nativ et al. LIVER TRANSPLANTATION
- The estimation of tumor cell percentage for molecular testing by pathologists is not accurate
- (2013) Alexander J J Smits et al. MODERN PATHOLOGY
- Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer
- (2012) S. T. Martin et al. BRITISH JOURNAL OF SURGERY
- Digital Pathology and Image Analysis for Robust High-Throughput Quantitative Assessment of Alzheimer Disease Neuropathologic Changes
- (2012) Janna Hackett Neltner et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue
- (2012) Steven J Potts et al. LABORATORY INVESTIGATION
- Scientific and Regulatory Policy Committee (SRPC) Paper
- (2012) Richard E. Long et al. TOXICOLOGIC PATHOLOGY
- Computerized Histologic Image-Based Risk Score (IbRiS) Classifier for ER+ Breast Cancer.
- (2010) S. Ganesan et al. CANCER RESEARCH
- Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
- (2010) Monique Maas et al. LANCET ONCOLOGY
- Interobserver Variability in Histologic Evaluation of Radical Prostatectomy Between Central and Local Pathologists: Findings of TAX 3501 Multinational Clinical Trial
- (2010) George J. Netto et al. UROLOGY
- Digital pathology in drug discovery and development: multisite integration
- (2009) Steven J. Potts DRUG DISCOVERY TODAY
- High efficacy of pre-operative trastuzumab combined with paclitaxel following doxorubicin & cyclophosphamide in operable breast cancer
- (2008) Shani Paluch-Shimon et al. ACTA ONCOLOGICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started